MedTrace Logo

The Role of Neuromodulators in Refractory Functional Dyspepsia

NCT05099913 · Status: UNKNOWN · Phase: NA · Type: INTERVENTIONAL · Enrollment: 220

Last updated 2022-03-31

No results posted yet for this study

Summary

The study was designed to investigate the effect of central neuromodulators on refractory functional dyspepsia

Conditions

  • Dyspepsia
  • Functional Gastrointestinal Disorders
  • Antidepressant Discontinuation Syndrome
  • Antidepressant Drug Adverse Reaction

Interventions

DRUG

Deanxit

Central neuromodulators was applied in refractory FD patients for different time

Sponsors & Collaborators

  • RenJi Hospital

    lead OTHER

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
NONE
Model
PARALLEL

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2020-08-01
Primary Completion
2022-10-01
Completion
2022-12-30

Countries

  • China

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT05099913 on ClinicalTrials.gov